Top connectivity services company will leverage Rhapsody EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners
Boston, MA – August 18, 2022 – Rhapsody, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Rhapsody EMPI to better serve its healthcare clients and partners. This integration will bolster MedAllies’ identity data management capabilities to increase the accuracy of the data it exchanges for the benefit of all.
As the healthcare industry continues to shift toward a more consumer-centric approach to interoperability, MedAllies maintains its commitment to providing connectivity services to thousands of healthcare providers and organizations across the country. The company turned to Rhapsody for its proven identity management solutions and unparalleled approach to facilitating real-time data exchange.
“MedAllies realized the pressing need to invest in EMPI technology, and we are excited to partner and provide solutions that will strengthen the company’s data exchange services,” said Scott Galbari, president and COO of Rhapsody. “MedAllies understands the need to ensure the data it helps customers exchange is accurate so as not to negatively impact care and recognizes that more accurate data can better support MedAllies’ own strategic initiatives. We applaud MedAllies for prioritizing this investment and having the vision to bring this crucial capability to its customers.”
Rhapsody EMPI has the flexibility to support on-premises and cloud deployments with the ability to adapt and scale over time. It offers options for resolution of data issues using referential data as well as manual data remediation. Beyond its proven technology, Rhapsody offers a world-class, hands-on approach to customer support and training to ensure its clients maximize their investment in patient data accuracy.
“Our clients and partners have spoken clearly: They need identity data solutions to be confident in the accuracy of the data that powers their businesses,” said Tom Visotsky, chief commercial officer at MedAllies. “After a great deal of due diligence, we came to the conclusion that Rhapsody offers the most mature and robust EMPI solution on the market. We are excited to bring this powerful capability to meet our clients’ needs, fortify our care quality offering, and help our partners to thrive in a data-driven and consumer-focused healthcare environment.”
To learn more, please visit Rhapsody in booth #22 at the Civitas Conference August 21-24 in San Antonio, Texas.
